Authority: IC 25-26-13-4; IC 25-26-25-6

Affected: IC 25-26-25-6

Sec. 9. (a) Once the appropriate self-administered hormonal contraceptive has been determined, the pharmacist shall offer to provide the patient counseling about the therapy. Counseling may include, but is not limited to, the following:

(1) The name and description of the medicine.

(2) The dosage form, dosage, and route of administration.

(3) Special directions and precautions.

(4) Common adverse effects or interactions and therapeutic contraindications that may be encountered, including their avoidance and the action required if they occur.

(5) Techniques for self-monitoring drug therapy.

(6) Proper storage.

(7) Prescription refill information.

(8) Action to be taken if a dose is missed.

(9) The need for backup contraception.

(10) The importance of seeing the patient's practitioner annually to obtain recommended tests and screening.

(11) The effectiveness and availability of long-acting reversible contraceptives as an alternative to hormonal contraceptive patches or self-administered hormonal contraceptives.

(12) That hormonal contraceptive patches and self-administered hormonal contraceptives do not protect against sexually transmitted infections.

(b) A patient experiencing side effects should be referred to a primary care or women's health practitioner for further evaluation and treatment.

(Indiana Board of Pharmacy; 856 IAC 1-43-9; filed Mar 26, 2026, 3:03 p.m.: 20260422-IR-856250798FRA)